Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Impax Laboratories Inc. (NasdaqNM:IPXL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Reports
Recent Events
Aug 22Price hit new 52-week high ($17.11)
Location
30831 Huntwood Avenue
Hayward, CA 94544
Phone: (215) 289-2220
Email: invest@impaxlabs.com
Employees (last reported count): 112
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 67%
·Over the last 6 months:
 · one insider sell; 6,000  shares
·Institutional: 28% (84% of float)
(43 institutions)
·Net Inst. Buying: 817.0K shares (+6.06%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Impax Laboratories Inc. (Impax) is a specialty pharmaceutical company focused on the development and commercialization of specialty generic and branded pharmaceuticals, utilizing its in-house development and formulation expertise. As of December 31, 2000, the Company had four Abbreviated New Drug Applications (ANDAs) approved and eight ANDAs pending at the FDA. The pending ANDA filings are for generic versions of branded pharmaceuticals whose 2000 U.S. sales were approximately $5.5 billion. Impax has approximately 20 other products it intends to file as ANDAs in various stages of development. The Company has three branded projects under development. The Company expects to file its first application from these projects in the second half of 2001. The Company currently markets 16 generic pharmaceuticals.
More from Market Guide: Expanded Business Description

Financial Summary
IPXL is engaged in the development of generic and branded pharmaceutical products. For the six months ended 6/30/01, revenues decreased 52% to $2.9 million. Net loss before accounting change increased 24% to $11.5 million. Revenues reflect lower sales due to the discontinuation of certain products. Higher loss reflects a negative gross margin due to unabsorbed costs of the excess capacity and start-up operating costs of a new plant.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Charles Hsiao, Ph.D., 56
Chairman, Co-CEO
$122K
Barry Edwards, 43
Co-CEO
225K
Larry Hsu, Ph.D., 51
Pres, COO
122K
Cornel Spiegler, 55
CFO
167K
David Doll
Sr. VP of Sales and Marketing
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:IPXLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 26-Dec-2000
$4.875
Recent Price$16.05 
52-Week High
on 22-Aug-2001
$17.11 
Daily Volume (3-month avg)176.8K
Daily Volume (10-day avg)149.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+176.1%
52-Week Change
relative to S&P500
+270.4%
Share-Related Items
Market Capitalization$736.3M
Shares Outstanding45.9M
Float15.1M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.26 
Earnings (ttm)-$0.85 
Earnings (mrq)-$0.15 
Sales (ttm)$0.23 
Cash (mrq)$1.03 
Valuation Ratios
Price/Book (mrq)12.76 
Price/EarningsN/A 
Price/Sales (ttm)71.07 
Income Statements
Sales (ttm)$7.65M
EBITDA (ttm)-$21.2M
Income available to common (ttm)-$26.6M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-37.67%
Return on Equity (ttm)-80.74%
Financial Strength
Current Ratio (mrq)10.65 
Debt/Equity (mrq)0.48 
Total Cash (mrq)$46.0M
Short Interest
As of 8-Aug-2001
Shares Short121.0K
Percent of Float0.8%
Shares Short
(Prior Month)
138.0K
Short Ratio0.67 
Daily Volume182.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.